FDA Guidance for Industry: Bispecific Antibody Development Programs

Title:
FDA Guidance for Industry: Bispecific Antibody Development Programs

https://www.gmp-compliance.org/files/guidemgr/35086505fnl Bispecific Antibody Development Programs Final Guidance 2019-768.pdf

Origin/Publisher:

FDA

Content:
This guidance provides recommendations to assist industry and other parties involved in the development of bispecific antibodies.

Go back